Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 30;19(6):733-754.
doi: 10.6004/jnccn.2021.0027.

Pediatric Hodgkin Lymphoma, Version 3.2021

Jamie E Flerlage  1 , Susan M Hiniker  2 , Saro Armenian  3 , Ellen C Benya  4 , Adam J Bobbey  5 , Vivian Chang  6 , Stacy Cooper  7 , Don W Coulter  8 , Branko Cuglievan  9 , Bradford S Hoppe  10 , Leidy Isenalumhe  11 , Kara Kelly  12 , Leslie Kersun  13 , Adam J Lamble  14 , Nicole A Larrier  15 , Jeffrey Magee  16 , Kwadwo Oduro  17 , Martha Pacheco  18 , Anita P Price  19 , Kenneth B Roberts  20 , Christine M Smith  21 , Aliyah R Sohani  22 , Erin M Trovillion  23 , Emily Walling  24 , Ana C Xavier  25 , Jennifer L Burns  26 , Mallory Campbell  26
Affiliations

Pediatric Hodgkin Lymphoma, Version 3.2021

Jamie E Flerlage et al. J Natl Compr Canc Netw. .

Abstract

Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.

PubMed Disclaimer

Comment in

LinkOut - more resources